Murj®, a cardiac device management software and services company, today announced the release of the Murj Remote Patient Monitoring Platform (RPM), a remote physiologic monitoring software platform ...

A recent BMC Public Health study analyzes self-monitoring data from Chinese adults who participated in a group weight loss intervention using a mixed-methods approach. Study: Why more successful? An ...

Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...

Billy Abbott, a retired Army medic, wakes at 6 every morning, steps on his bathroom scale and uses a cuff to take his blood pressure. The devices send those measurements electronically to his doctor ...

The FDA has approved Signos, an AI-powered app that uses continuous glucose monitoring to guide weight loss and personalized nutrition. Cheaper than GLP-1 drugs, Signos offers real-time feedback on ...

Signos, maker of an over-the-counter glucose monitoring system for weight management, announced it secured $20 million in funding and a partnership with continuous glucose monitoring company Dexcom.

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, ...